respiratori
tract
infect
requir
earli
diagnosi
adequ
treatment
antibiot
overus
increment
antibiot
resist
increas
need
accur
distinguish
bacteri
viral
infect
investig
diagnost
perform
calprotectin
respiratori
tract
infect
compar
perform
heparin
bind
protein
hbp
procalcitonin
pct
biomark
analyz
patient
viral
respiratori
infect
patient
bacteri
pneumonia
mycoplasma
pneumonia
streptococc
tonsil
n
infect
includ
mycoplasma
greater
perform
pct
hbp
rapid
determin
calprotectin
may
improv
manag
respiratori
tract
infect
allow
precis
diagnosi
select
use
antibiot
releas
upon
activ
turnov
neutrophil
recogn
import
marker
neutrophil
mediat
inflamm
bacteri
viral
infect
caus
acut
phase
respons
counterattack
infect
reduc
damag
infect
lead
activ
innat
immun
system
earli
defens
mechan
major
function
innat
immun
includ
recruit
immun
cell
site
infect
activ
complement
cascad
activ
white
blood
cell
elimin
microorgan
rapid
process
neutrophil
first
cell
reach
affect
locat
neutrophil
activ
marker
releas
neutrophil
upon
activ
activ
marker
store
granula
cytoplasm
rapidli
releas
neutrophil
need
de
novo
synthesi
neutrophil
marker
earlier
marker
neutrophil
activ
caus
bacteri
infect
comparison
format
new
white
blood
cell
synthesi
protein
aim
studi
investig
perform
calprotectin
marker
bacteri
infect
possibl
distinguish
bacteri
mycoplasma
viral
respiratori
tract
infect
result
patient
character
serum
plasma
sampl
collect
patient
fever
symptom
respiratori
infect
asymptomat
healthi
subject
infect
patient
classifi
bacteri
mycoplasma
viral
caus
diseas
primari
studi
group
includ
patient
confirm
etiolog
respiratori
infect
studi
group
consist
subject
asymptomat
healthi
control
bacteri
infect
mycoplasma
infect
viral
infect
tabl
distribut
calprotectin
procalcitonin
hbp
concentr
patient
respiratori
tract
infect
separ
verifi
clinic
diagnosi
present
fig
compar
healthi
subject
three
biomark
significantli
elev
diagnost
group
p
calprotectin
level
significantli
higher
patient
bacteri
pneumonia
mycoplasma
pneumonia
zzz
p
streptococc
tonsil
z
p
compar
level
patient
viral
infect
concentr
pct
bacteri
pneumonia
significantli
higher
zzz
p
concentr
viral
group
wherea
level
streptococc
tonsil
mycoplasma
pneumonia
significantli
differ
compar
level
patient
viral
infect
hbp
concentr
significantli
differ
mycoplasma
bacteri
infect
compar
viral
infect
result
summar
tabl
figur
show
roc
curv
diagnost
perform
three
biomark
differenti
bacteri
pneumonia
fig
mycoplasma
pneumonia
fig
viral
infect
perform
calprotectin
differenti
bacteri
mycoplasma
viral
infect
higher
perform
hbp
pct
promin
differenti
mycoplasmaand
viral
infect
tabl
auroc
result
three
biomark
summar
distinct
diagnosi
bacteri
pneumonia
mycoplasma
pneumonia
viral
infect
aim
current
studi
evalu
perform
calprotectin
neutrophil
activ
marker
diagnosi
acut
respiratori
infect
differenti
bacteri
viral
infect
perform
calprotectin
compar
perform
heparin
bind
protein
hbp
also
produc
neutrophil
store
azurophil
granul
within
cell
procalcitonin
pct
wide
use
marker
bacteri
infect
found
significantli
higher
plasma
calprotectin
valu
patient
bacteri
respiratori
infect
pneumonia
tonsil
mycoplasma
patient
viral
respiratori
infect
healthi
control
auc
calprotectin
pct
higher
auc
hbp
use
diagnosi
bacteri
pneumonia
mycoplasma
pneumonia
streptococc
tonsil
fig
tabl
furthermor
auc
calprotectin
significantli
higher
pct
hbp
discrimin
mycoplasma
infect
viral
infect
data
support
clinic
use
calprotectin
diagnosi
respiratori
infect
indic
greater
perform
calprotectin
compar
hbp
pct
distinguish
bacteri
mycoplasma
respiratori
infect
viral
infect
find
support
observ
studi
limit
clinic
util
procalcitonin
diagnosi
bacteri
pneumonia
respons
calprotectin
bacteri
respiratori
infect
well
line
previou
report
demonstr
increas
calprotectin
sepsi
well
inflammatori
condit
neutrophil
activ
append
synov
prosthet
joint
infect
perform
crp
white
blood
cell
count
wbc
evalu
studi
sinc
use
clinic
judgment
diagnosi
bia
toward
two
biomark
hinder
accur
tabl
concentr
studi
biomark
possibl
differenti
healthi
popul
infect
patient
well
patient
bacteri
viral
infect
z
p
bacteri
viral
mycoplasma
infect
vs
healthi
popul
zzz
p
z
p
bacteri
mycoplasma
infect
vs
viral
infect
wwwnaturecomscientificreport
wwwnaturecomscientificreport
evalu
diagnost
perform
earlier
public
shown
crp
power
tool
rule
patient
bacteri
infect
viral
infect
howev
consider
overlap
bacteri
infect
indic
crp
less
use
distinct
studi
certain
limit
singlecent
studi
limit
number
patient
differ
diagnost
group
howev
diagnos
well
defin
confirm
xray
bloodtissu
cultur
andor
wwwnaturecomscientificreport
wwwnaturecomscientificreport
pcr
analysi
data
suggest
measur
plasma
calprotectin
patient
suspect
respiratori
infect
feasibl
possibl
fast
test
result
result
studi
may
aid
design
futur
studi
present
studi
use
plasma
sampl
determin
calprotectin
hbp
coagul
process
necessari
prepar
serum
sampl
caus
activ
neutrophil
could
thu
lead
elev
level
calprotectin
hbp
analyz
serum
pct
affect
coagul
process
thu
analyz
serum
sampl
hbp
assay
microtiterbas
elisa
associ
long
test
turnaround
time
test
format
requir
collect
number
sampl
prior
test
avail
commerci
procalcitonin
assay
either
microtit
base
develop
specif
assay
platform
platform
avail
laboratori
mean
sampl
may
sent
anoth
laboratori
test
also
increas
time
test
result
avail
calprotectin
assay
use
particl
enhanc
turbidimetr
assay
petia
assay
time
min
petia
technolog
appli
routin
chemistri
analyz
avail
hospit
laboratori
allow
short
test
turnaround
time
comparison
elisa
design
measur
singl
sampl
thu
shorten
analysi
time
significantli
import
bacteri
infect
acut
condit
requir
rapid
test
result
conclus
calprotectin
procalcitonin
perform
better
hpb
distinguish
pneumonia
tonsil
caus
bacteria
viral
infect
furthermor
calprotectin
superior
hbp
procalcitonin
distinguish
respiratori
infect
caus
mycoplasma
virus
primari
care
infecti
diseas
unit
patient
result
indic
calprotectin
altogeth
sensit
hbp
procalcitonin
distinguish
bacteri
mycoplasma
viral
caus
respiratori
infect
inclus
criteria
patient
studi
fever
sign
symptom
respiratori
infect
inclus
diagnosi
patient
describ
detail
previous
exclus
criterion
known
chronic
viral
infect
human
immunodefici
viru
infect
hepat
addit
children
age
year
patient
could
give
inform
consent
exclud
studi
patient
admit
infecti
diseas
depart
univers
hospit
uppsala
primari
care
unit
uppsala
blood
sampl
drawn
start
antibiot
treatment
studi
approv
uppsala
region
ethic
committe
uppsala
sweden
part
studi
perform
accord
ethic
approv
swedish
european
regul
particip
gave
inform
consent
prior
inclus
studi
studi
healthi
individu
patient
confirm
etiolog
acut
respiratori
infect
includ
patient
bacteri
infect
viral
infect
healthi
control
consist
male
age
year
mean
sd
femal
age
year
mean
sd
age
gender
distribut
confirm
infect
shown
tabl
patient
group
clinic
find
assess
document
includ
white
blood
cell
count
crp
level
verifi
object
test
use
routin
diagnost
pneumonia
group
diagnosi
verifi
posit
chest
xray
support
posit
cultur
pcr
test
lower
respiratori
tract
sampl
diagnosi
respiratori
tract
infect
virus
exampl
influenza
ab
atyp
pneumonia
mycoplasma
pneumonia
support
pcr
test
sampl
respiratori
tract
viral
infect
dengu
fever
epsteinbarr
viru
cytomegaloviru
infect
support
iggigm
serolog
result
diagnosi
bacteri
infect
support
cultur
respiratori
tract
appropri
tonsil
diagnos
rapid
test
group
streptococcu
support
posit
cultur
biomark
calprotectin
measur
plasma
sampl
turbidimetr
method
gentian
norway
mindray
bs
instrument
heparin
bind
protein
hbp
azurocidin
analyz
commerci
avail
elisa
hycult
biotech
uden
netherland
procalcitonin
analyz
use
sandwich
elisa
ehpct
thermo
fisher
scientif
frederick
md
usa
calprotectin
hbp
analyz
edta
plasma
procalcitonin
analyz
serum
plasma
serum
tube
collect
time
statist
data
group
express
median
interquartil
rang
iq
wherev
appropri
comparison
group
perform
nonparametr
mannwhitneyu
test
clinic
perform
biomark
test
receiv
oper
characterist
roc
give
area
curv
auc
auc
compar
cstatist
youden
index
calcul
estim
optim
cutoff
use
defin
sensit
specif
posit
neg
likelihood
analys
perform
statist
program
medcalc
statist
softwar
ostend
belgium
tabl
auroc
result
three
biomark
summar
distinct
bacteri
mycoplasma
pneumonia
vs
respiratori
viral
infect
p
p
calprotectin
vs
biomark
differenti
bacteri
mycoplasma
viral
infect
